Nonsurgical management of Chiari malformation type I and syringomyelia and the potential role of inflammation in the pathophysiology of Chiari-associated syrinx: illustrative cases
Journal of Neurosurgery: Case Lessons · 2026-11-23 · 12 (21)
DOI: 10.3171/case26496 ↗At a glance
Journal article in Journal of Neurosurgery: Case Lessons, published on 2026-11-23. Written by Farrell K. Landwehr and 3 co-authors. 26 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
BACKGROUND Chiari malformation type I (CM-I) is characterized by cerebellar tonsil position ≥ 5 mm below the foramen magnum, which can disrupt CSF flow and lead to syringomyelia. Pro-inflammatory processes have been associated with heightened CNS inflammation and altered CSF dynamics, mechanisms that may contribute to CM-I and syringomyelia pathogenesis, although the precise relationship remains uncertain. Anti-inflammatory interventions, including dietary modification and pharmacological therapies such as metformin, may offer neuroprotective benefits by mitigating neuroinflammation and improving neurological outcomes. OBSERVATIONS The authors describe the cases of 2 pediatric patients with CM-I and syringomyelia who demonstrated clinical and radiographic improvement following anti-inflammatory interventions. Both patients initially presented with symptomatic CM-I, cerebellar tonsil position > 5 mm below the foramen magnum, and syringomyelia. A 7-year-old female was started on a diet intended to reduce inflammation and restrict gluten and sugar and subsequently demonstrated stable tonsil position, reduced syrinx size, and symptomatic improvement of hand paresthesias. A 9-year-old female began metformin therapy and experienced stable tonsil position, reduction in a multiloculated syrinx, and resolution of symptoms. LESSONS These cases suggest that anti-inflammatory interventions may contribute to symptom improvement and syrinx reduction in CM-I–associated syringomyelia, supporting further investigation into inflammation as a therapeutic target in CM-I pathogenesis. https://thejns.org/doi/10.3171/CASE26496
Cite
APA
Landwehr, F. K., Pan, S., Gupta, V. P., & Strahle, J. M. (2026). Nonsurgical management of Chiari malformation type I and syringomyelia and the potential role of inflammation in the pathophysiology of Chiari-associated syrinx: illustrative cases. Journal of Neurosurgery: Case Lessons, 12(21). https://doi.org/10.3171/case26496
Vancouver
Landwehr FK, Pan S, Gupta VP, Strahle JM. Nonsurgical management of Chiari malformation type I and syringomyelia and the potential role of inflammation in the pathophysiology of Chiari-associated syrinx: illustrative cases. Journal of Neurosurgery: Case Lessons. 2026;12(21). doi:10.3171/case26496
BibTeX
@article{Landwehr2026,
author = {Landwehr, Farrell K. and Pan, Shelei and Gupta, Vivek P. and Strahle, Jennifer M.},
title = {Nonsurgical management of Chiari malformation type I and syringomyelia and the potential role of inflammation in the pathophysiology of Chiari-associated syrinx: illustrative cases},
journal = {Journal of Neurosurgery: Case Lessons},
year = {2026},
volume = {12},
number = {21},
doi = {10.3171/case26496}
}
EUVIMED